Evidence map›Paper›PMID 32487561›Full record

ArticleJournal of the American Society of Nephrology : JASN2020

Neutrophil Gelatinase-Associated Lipocalin Protects from ANCA-Induced GN by Inhibiting T

Adrian Schreiber, Anthony Rousselle, Jan Klocke, Sebastian Bachmann, Suncica Popovic, Julia Bontscho, Kai M Schmidt-Ott, Volker Siffrin, Uwe Jerke, Muhammad Imtiaz Ashraf and 2 more

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. New Biomarkers for Systemic Necrotizing Vasculitides.Journal of clinical medicine · 2024
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Adrian SchreiberExperimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité - Berlin University of Medicine, Corporate Member of Free University of Berlin, Humboldt University of Berlin, Berlin Institute of Health, Berlin, Germany adrian.schreiber@charite.de.
Anthony RousselleExperimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité - Berlin University of Medicine, Corporate Member of Free University of Berlin, Humboldt University of Berlin, Berlin Institute of Health, Berlin, Germany.
Jan KlockeNephrology and Medical Intensive Care Medicine, Charité - Berlin University of Medicine, Berlin, Germany.
Sebastian BachmannInstitute of Vegetative Anatomy, Charité - Berlin University of Medicine, Berlin, Germany.
Suncica PopovicInstitute of Vegetative Anatomy, Charité - Berlin University of Medicine, Berlin, Germany.
Julia BontschoNephrology and Medical Intensive Care Medicine, Charité - Berlin University of Medicine, Berlin, Germany.
Kai M Schmidt-OttNephrology and Medical Intensive Care Medicine, Charité - Berlin University of Medicine, Berlin, Germany.
Volker SiffrinExperimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité - Berlin University of Medicine, Corporate Member of Free University of Berlin, Humboldt University of Berlin, Berlin Institute of Health, Berlin, Germany.
Uwe JerkeExperimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité - Berlin University of Medicine, Corporate Member of Free University of Berlin, Humboldt University of Berlin, Berlin Institute of Health, Berlin, Germany.
Muhammad Imtiaz AshrafDepartment of Surgery, Campus Charité Mitte I Campus Virchow Klinikum, Charité - Berlin University of Medicine, Berlin, Germany.
Ulf PanzerIII. Medical Clinic, Division of Translational Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Ralph KettritzExperimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité - Berlin University of Medicine, Corporate Member of Free University of Berlin, Humboldt University of Berlin, Berlin Institute of Health, Berlin, Germany.
Charité - Universitätsmedizin Berlin · DEFreie Universität Berlin · DEMax Delbrück Center · DEUniversity Medical Center Hamburg-Eppendorf · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNeutrophil gelatinase-associated lipocalin (NGAL) is a diagnostic marker of intrinsic kidney injury produced by damaged renal cells and by neutrophils. ANCA-associated vasculitis features necrotizing crescentic GN (NCGN), and ANCA-activated neutrophils contribute to NCGN. Whether NGAL plays a mechanistic role in ANCA-associated vasculitis is unknown.

methodsWe measured NGAL in patients with ANCA-associated vasculitis and mice with anti-myeloperoxidase (anti-MPO) antibody-induced NCGN. We compared kidney histology, neutrophil functions, T cell proliferation and polarization, renal infiltrating cells, and cytokines in wild-type and NGAL-deficient chimeric mice with anti-MPO antibody-induced NCGN. To assess the role of T

resultsMice and patients with active ANCA-associated vasculitis demonstrated strongly increased serum and urinary NGAL levels. ANCA-stimulated neutrophils released NGAL. Mice with NGAL-deficient bone marrow developed worsened MPO-ANCA-induced NCGN. Intrinsic neutrophil functions were similar in NGAL-deficient and wild-type neutrophils, whereas T cell immunity was increased in chimeric mice with NGAL-deficient neutrophils with more renal infiltrating T

conclusionsOur findings support that bone marrow-derived, presumably neutrophil, NGAL protects from ANCA-induced NCGN by downregulating T

Indexed as

AdultAgedAged, 80 and overAnimalsAntibodies, Antineutrophil CytoplasmicAnti-Neutrophil Cytoplasmic Antibody-Associated VasculitisCD28 AntigensCD3 ComplexCD4-Positive T-LymphocytesCell ProliferationChimeraDisease Models, AnimalFemaleGlomerulonephritisHumansImmunity, CellularAntibodies, Antineutrophil CytoplasmicCD28 AntigensCD3 ComplexIl17a protein, mouseInterleukin-17LCN2 protein, humanLcn2 protein, mouseLipocalin-2PeroxidaseSiderophoresANCA glomerulonephritisneutrophilngalTH17

Identifiers

PMID32487561
PMCPMC7350985
OpenAlexW3029598181

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.